Brian Lu

2.4k citations
56 papers · 1.6k · 1 hit paper · h-index 19

Impact in

Papers in

    • Pancreatic and Hepatic Oncology Research 27
    • Cancer Treatment and Pharmacology 9
    • Colorectal Cancer Treatments and Studies 6
    • Cancer Genomics and Diagnostics 22

Brian Lu

53 papers receiving 1.6k citations

Brian Lu's Hit Papers

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial 2015 · 504 citations
5040+3+7Years since publication100200300400500

Peers

Brian Lu
Comparison fields: 5 of 109
  • Oncology 943
  • Cancer Research 396
  • Pulmonary and Respiratory Medicine 342
  • Epidemiology 293
  • Molecular Biology 510
Replace Tai Hato with:
Tai Hato Japan
Takanori Goi Japan
Satoru Moriyama Japan
Ru Jia China
Renê Gerhard Brazil
Nagahide Matsubara Japan
Esther Bertrán Spain
Fumiyoshi Fujishima Japan
Yoichi Kameda Japan
Brian Lu relative to Tai Hato Japan Tai Hato's profile →
Citations per field
00.5×1.7×
Tai Hato · 1×
Citations per year

Countries citing papers authored by Brian Lu

Since Specialization
Citations

This map shows the geographic impact of Brian Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Lu more than expected).

Fields of papers citing papers by Brian Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Lu. The network helps show where Brian Lu may publish in the future.

Co-authors

The 25 scholars most cited alongside Brian Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brian Lu Line = papers co-authored together Brian Lu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
Hit paper breakdown →
2015504
2 201997
3 199888
4 202081
5 201679
6 199774
7 201674
8 201663
9 199946
10 201545
11 201636
12 202133
13 201531
14 201427
15 201126
16 201621
17 201721
18 201720
19 201820
20 202118

About Brian Lu

Brian Lu is a scholar working on Oncology, Cancer Research, Molecular Biology, Surgery and Epidemiology, having authored 56 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (27 papers), Cancer Genomics and Diagnostics (22 papers), Cancer Treatment and Pharmacology (9 papers), Pancreatic function and diabetes (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Renal cell carcinoma treatment (5 papers), Diabetes and associated disorders (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). The work is most often cited by research in Oncology (943 citations), Cancer Research (396 citations), Pulmonary and Respiratory Medicine (342 citations), Epidemiology (293 citations) and Molecular Biology (510 citations). Brian Lu has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include David Goldstein, Daniel D. Von Hoff, Josep Tabernero, Giampaolo Tortora, Volker Kunzmann, Alfredo Romano, Luís Teixeira, Salvatore Siena, Jean‐Luc Van Laethem and Robert H. El-Maraghi. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Journal of Cell Biology, Pancreas and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact